Further supporting the notion, analyses of publically available high-throughput datasets24 revealed that in German male patients diagnosed with varying stages of NAFLD, there exist general trends that CRTC1 expression is reduced compared to healthy controls while expression of genes promoting hepatic lipid accumulation is elevated (Supplementary Fig. S6). This evidence concerns the gene CRTC1 and metabolic dysfunction-associated steatotic liver disease.